Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Comment by Tandaboon Aug 29, 2020 4:00pm
295 Views
Post# 31475625

RE:RE:RE:Things we know are coming!

RE:RE:RE:Things we know are coming! Burnout, you are correct. FDA approval only covers the US. Other countries have their own approval systems such as Health Canada, Europe, etc. I'm guessing others are very interested in SONA achieving FDA EUA because it will give implied credibility and validity to their test/products/procedures. That said, I too wonder, yet anticipate and expect, other jurisdictions to move ahead with the antigen test purchases irrespective of the US. IMO those discussions are on-going as SONA and its pipeline partners work out the final logistics of manufacturing, distribution, sales volumes, even pricing levels. This is going to move forward. This is, presently, the best the world has to focus on for its simplicity, ease of use and soon to be mass availability. Likely a few weeks yet or sooner if lucky. In the meantime the stock will suffer more hits as impatience grows. Steady as she goes. GLTA!
<< Previous
Bullboard Posts
Next >>